Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7272 USD | +10.18% | +10.48% | +113.76% |
16/04 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
16/04 | Monopar Therapeutics Inc. Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings | CI |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 40 | 01/14/01 | |
Kim Tsuchimoto
DFI | Director of Finance/CFO | 61 | 01/15/01 |
Laura Kelly
CTO | Chief Tech/Sci/R&D Officer | - | 18/21/18 |
Andrew Cittadine
COO | Chief Operating Officer | 52 | 01/21/01 |
Patrice Rioux
CTO | Chief Tech/Sci/R&D Officer | 73 | 01/16/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brown
BRD | Director/Board Member | 67 | 01/14/01 |
Arthur Klausner
BRD | Director/Board Member | 64 | 01/17/01 |
Kim Tsuchimoto
DFI | Director of Finance/CFO | 61 | 01/15/01 |
Founder | 71 | 01/14/01 | |
Raymond Anderson
BRD | Director/Board Member | 82 | 01/17/01 |
Founder | 40 | 01/14/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,454,925 | 8,316,964 ( 47.65 %) | 0 | 47.65 % |
Company contact information
Monopar Therapeutics, Inc.
1000 Skokie Boulevard Suite 350
60091, Wilmette
+847 388 0349
http://www.monopartx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.76% | 12.69M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- MNPR Stock
- Company Monopar Therapeutics Inc.